Mouse models of breast cancer

Kazuhito Sakamoto, Jeffrey W. Schmidt, Kay Uwe Wagner

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Breast cancer is the most common cause of cancer death in women worldwide. This malignancy is a complex disease, which is defi ned by an intrinsic heterogeneity on the histopathological and molecular level as well as response to therapy and outcome. In addition to classical histopathological features, breast cancer can be categorized into at least fi ve major subtypes based on comprehensive gene expression profi ling: luminal A, luminal B, basal-like, ERBB2-positive, and normal-like breast cancer. Genetically engineered mouse models can serve as tools to study the molecular underpinnings for this disease. Given the genetic complexity that drives the initiation and progression of individual breast cancer subtypes, it is evident that certain models can refl ect only particular aspects of this malignancy. In this book chapter, we will primarily focus on advances in modeling breast cancer at defi ned stages of carcinogenesis using genetically engineered mice. We will discuss the ability as well as shortcomings of these models to faithfully recapitulate the spectrum of human breast cancer subtypes.

Original languageEnglish (US)
Title of host publicationMouse Models of Cancer: Methods and Protocols
PublisherSpringer New York
Pages47-71
Number of pages25
ISBN (Print)9781493922970, 9781493922963
DOIs
StatePublished - Jan 30 2015

Fingerprint

breast neoplasms
animal models
Breast Neoplasms
Neoplasms
carcinogenesis
Cause of Death
Carcinogenesis
death
Gene Expression
gene expression
therapeutics
neoplasms
mice

Keywords

  • Cancer progression
  • Molecular subtypes
  • Mouse models
  • Transgene
  • Tumorigenesis

ASJC Scopus subject areas

  • Medicine(all)
  • Agricultural and Biological Sciences(all)

Cite this

Sakamoto, K., Schmidt, J. W., & Wagner, K. U. (2015). Mouse models of breast cancer. In Mouse Models of Cancer: Methods and Protocols (pp. 47-71). Springer New York. https://doi.org/10.1007/978-1-4939-2297-0_3

Mouse models of breast cancer. / Sakamoto, Kazuhito; Schmidt, Jeffrey W.; Wagner, Kay Uwe.

Mouse Models of Cancer: Methods and Protocols. Springer New York, 2015. p. 47-71.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sakamoto, K, Schmidt, JW & Wagner, KU 2015, Mouse models of breast cancer. in Mouse Models of Cancer: Methods and Protocols. Springer New York, pp. 47-71. https://doi.org/10.1007/978-1-4939-2297-0_3
Sakamoto K, Schmidt JW, Wagner KU. Mouse models of breast cancer. In Mouse Models of Cancer: Methods and Protocols. Springer New York. 2015. p. 47-71 https://doi.org/10.1007/978-1-4939-2297-0_3
Sakamoto, Kazuhito ; Schmidt, Jeffrey W. ; Wagner, Kay Uwe. / Mouse models of breast cancer. Mouse Models of Cancer: Methods and Protocols. Springer New York, 2015. pp. 47-71
@inbook{d606633cc74f4a74a9fba3d1fd1c388f,
title = "Mouse models of breast cancer",
abstract = "Breast cancer is the most common cause of cancer death in women worldwide. This malignancy is a complex disease, which is defi ned by an intrinsic heterogeneity on the histopathological and molecular level as well as response to therapy and outcome. In addition to classical histopathological features, breast cancer can be categorized into at least fi ve major subtypes based on comprehensive gene expression profi ling: luminal A, luminal B, basal-like, ERBB2-positive, and normal-like breast cancer. Genetically engineered mouse models can serve as tools to study the molecular underpinnings for this disease. Given the genetic complexity that drives the initiation and progression of individual breast cancer subtypes, it is evident that certain models can refl ect only particular aspects of this malignancy. In this book chapter, we will primarily focus on advances in modeling breast cancer at defi ned stages of carcinogenesis using genetically engineered mice. We will discuss the ability as well as shortcomings of these models to faithfully recapitulate the spectrum of human breast cancer subtypes.",
keywords = "Cancer progression, Molecular subtypes, Mouse models, Transgene, Tumorigenesis",
author = "Kazuhito Sakamoto and Schmidt, {Jeffrey W.} and Wagner, {Kay Uwe}",
year = "2015",
month = "1",
day = "30",
doi = "10.1007/978-1-4939-2297-0_3",
language = "English (US)",
isbn = "9781493922970",
pages = "47--71",
booktitle = "Mouse Models of Cancer: Methods and Protocols",
publisher = "Springer New York",

}

TY - CHAP

T1 - Mouse models of breast cancer

AU - Sakamoto, Kazuhito

AU - Schmidt, Jeffrey W.

AU - Wagner, Kay Uwe

PY - 2015/1/30

Y1 - 2015/1/30

N2 - Breast cancer is the most common cause of cancer death in women worldwide. This malignancy is a complex disease, which is defi ned by an intrinsic heterogeneity on the histopathological and molecular level as well as response to therapy and outcome. In addition to classical histopathological features, breast cancer can be categorized into at least fi ve major subtypes based on comprehensive gene expression profi ling: luminal A, luminal B, basal-like, ERBB2-positive, and normal-like breast cancer. Genetically engineered mouse models can serve as tools to study the molecular underpinnings for this disease. Given the genetic complexity that drives the initiation and progression of individual breast cancer subtypes, it is evident that certain models can refl ect only particular aspects of this malignancy. In this book chapter, we will primarily focus on advances in modeling breast cancer at defi ned stages of carcinogenesis using genetically engineered mice. We will discuss the ability as well as shortcomings of these models to faithfully recapitulate the spectrum of human breast cancer subtypes.

AB - Breast cancer is the most common cause of cancer death in women worldwide. This malignancy is a complex disease, which is defi ned by an intrinsic heterogeneity on the histopathological and molecular level as well as response to therapy and outcome. In addition to classical histopathological features, breast cancer can be categorized into at least fi ve major subtypes based on comprehensive gene expression profi ling: luminal A, luminal B, basal-like, ERBB2-positive, and normal-like breast cancer. Genetically engineered mouse models can serve as tools to study the molecular underpinnings for this disease. Given the genetic complexity that drives the initiation and progression of individual breast cancer subtypes, it is evident that certain models can refl ect only particular aspects of this malignancy. In this book chapter, we will primarily focus on advances in modeling breast cancer at defi ned stages of carcinogenesis using genetically engineered mice. We will discuss the ability as well as shortcomings of these models to faithfully recapitulate the spectrum of human breast cancer subtypes.

KW - Cancer progression

KW - Molecular subtypes

KW - Mouse models

KW - Transgene

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84954618773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954618773&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2297-0_3

DO - 10.1007/978-1-4939-2297-0_3

M3 - Chapter

C2 - 25636464

AN - SCOPUS:84954618773

SN - 9781493922970

SN - 9781493922963

SP - 47

EP - 71

BT - Mouse Models of Cancer: Methods and Protocols

PB - Springer New York

ER -